HOVON110/ReBeL Study: Results of the Phase I Part of a Randomized Phase I/II Study of Lenalidomide, Rituximab With or Without Bendamustine in Patients With Relapsed/Refractory Follicular Lymphoma. Issue 1 (February 2020)

• Record Type: Journal Article
• Authors: Stevens, Wendy B.C.; Bakunina, Katerina; Cuijpers, Marloes; Chamuleau, Martine; Beeker, Aart; Fijnheer, Rob; Hebart, Holger; Visser, Hein P.J.; Doorduijn, Jeanette K.; Linton, Kim; Dreyling, Martin; de Jong, Daphne; Kersten, Marie José
• Is Part Of: HemaSphere. Volume 4:Issue 1(2020)
• Publication Date: 2020-02
• Subjects: Hematology -- Periodicals; 616.15005
• DOI: 10.1097/HS9.0000000000000325
• Languages: English
• ISSNs: 2572-9241

Abstract

Abstract : Supplemental Digital Content is available in the text